Leading industry experts from some of the most influential pharmaceutical, biotech companies, and institutions in the world such as Bristol Myers Squibb, Boehringer Ingelheim, and the Huntsman Cancer Institute will provide insight on using high throughput surface plasmon resonance (SPR) technology to explore the full kinetic and epitope diversity of antibody libraries.
The symposia will take place in Cambridge, MA (September 10, 2019), San Diego, CA (September 17, 2019), San Francisco (September 19, 2019) and Munich, Germany (October 8, 2019). Presentations from leading industry experts and Carterra will demonstrate how high throughput SPR using the Carterra LSA™ is facilitating a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline. This essentially combines screening and detailed characterization in the same step to increase efficiency and productivity and to reduce expenditure during drug discovery and development. For detailed schedules and registration information for ...
